Howard J. Lim - Concepedia

Author

Howard J. Lim

BC Cancer Agency ORCID

Also Known As

Duc Le, H J Lim, H Lim, H. J. Lim, H. Lim, H.J. Lim, Hanae Lim, Hobin Lim, Howard J Lim, Howard J. Lim

395

Publications

4.8K

Citations

H-Index

104

Concepts

All Affiliations

BC Cancer Agency University of British Columbia Canada's Michael Smith Genome Sciences Centre Vancouver General Hospital Simon Fraser University

About

Howard J. Lim is an author at BC Cancer Agency specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	38	1.8K
2	Health Sciences	7	7	261
3	Engineering	3	3	233
4	Natural Sciences	1	1	171
5	Nursing	1	1	16

Howard J. Lim

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo, The Lancet Oncology First-line TherapyGastrointestinal OncologyMedicinePathologyMetastatic Gastric	2019	276
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer Eric Y. Stutheit-Zhao, Yaoqing Shen, Erin Pleasance, Clinical Cancer Research	2017	192
Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer Aalok Kumar, Hagen F. Kennecke, Daniel J. Renouf, Cancer	2014	175
Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine Murray S. Webb, Dawn Saxon, Frances M. P. Wong, Biochimica et Biophysica Acta (BBA) - Biomembranes Lipid PreparationMedicinal ChemistryEthylene GlycolBiochemistryPolymer-drug Conjugate	1998	171
Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes Erin Pleasance, Emma Titmuss, Laura Williamson, Nature Cancer Genomic LandscapesTumor HeterogeneityMedicineAdvanced Patient TumorsPathology	2020	167
<i>NRG1</i> Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in <i>KRAS</i> Wild-Type Pancreatic Ductal Adenocarcinoma Martin Jones, Laura Williamson, James T. Topham, Clinical Cancer Research	2019	157
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer Kerry S. Courneya, Janette L. Vardy, Christopher J. O’Callaghan, New England Journal of Medicine	2025	134
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival David F. Schaeffer, Daniel R Owen, Howard J. Lim, BMC Cancer	2010	124
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers Janessa Laskin, Steven J.M. Jones, Samuel Aparício, Molecular Case Studies EngineeringPathologyMultiomicsCancer RegistrationTumor Biology	2015	112
Image-Guided Biopsy in the Era of Personalized Cancer Care: Proceedings from the Society of Interventional Radiology Research Consensus Panel Alda L. Tam, Howard J. Lim, Ignacio I. Wistuba, Journal of Vascular and Interventional Radiology Personalized Cancer CareEngineeringMedical ImagingImage-guided BiopsyBiomedical Imaging	2015	111

Page 1